Telix Pharmaceuticals Gets FDA Approval for Prostate Cancer Screening Agent
Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for prostate cancer ...
CURE1d
FDA Approves Gozellix for Advanced PSMA-PET Imaging in Prostate Cancer
The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 ...
BioWorld23h
Have kit, will travel further: Telix PET-imaging agent approved by FDA
The U.S. FDA’s approval of Telix Pharmaceuticals Ltd.’s kit for preparing prostate-specific membrane antigen-PET imaging for prostate cancer widens the opportunities for patients who live far away ...
Oncology Nursing News1d
FDA Approves TLX007-CDx for Prostate Cancer Imaging
TLX007-CDx was approved by the FDA for PSMA-PET scanning in adult male patients with prostate cancer with suspected ...
Treating Alzheimer’s Challenges with Zentara’s Early Detection Strategy
Since Alzheimer’s advanced stage has no cure right now, the entire focus of Zentara is on prevention. For this purpose, it has identified two goals: make early Alzheimer’s diagnosis cheaper and give ...
Medical Device Network on MSN4d
Telix’s prostate cancer imaging agent approved in Brazil
Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer ...
The Manila Times1d
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food ...
Targeted Oncology1d
FDA OKs TLX007-CDx in Prostate Cancer Treatment
TLX007-CDx is a cold kit designed for the preparation of PSMA-targeted PET imaging for prostate cancer. It leverages ...